Items where authors include "Rédini, F."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 8.

Article

Jacques, C., Lamoureux, F., Baud'huin, M. et al. (8 more authors) (2016) Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1. Oncotarget. ISSN 1949-2553

Ando, K., Heymann, M.F., Stresing, V. et al. (3 more authors) (2013) Current Therapeutic Strategies and Novel Approaches in Osteosarcoma. Cancers, 5 (2). pp. 591-616. ISSN 2072-6694

Heymann, D. orcid.org/0000-0001-7777-0669 and Rédini, F. (2013) Targeted therapies for bone sarcomas. BoneKEy Reports, 2. 378. ISSN 2047-6396

Ando, K., Mori, K., Verrecchia, F. et al. (3 more authors) (2012) Molecular Alterations Associated with Osteosarcoma Development. Sarcoma, 2012. 523432. ISSN 1357-714X

Heymann, D. orcid.org/0000-0001-7777-0669 and Rédini, F. (2011) Bone sarcomas: pathogenesis and new therapeutic approaches. IBMS BoneKEy, 8 (9). pp. 402-414. ISSN 1940-8692

David, E., Blanchard, F., Heymann, M.F. et al. (4 more authors) (2011) The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets. Sarcoma, 2011. 932451. ISSN 1357-714X

Ando, K., Mori, K., Rédini, F. et al. (1 more author) (2008) RANKL/RANK/OPG: key therapeutic target in bone oncology. Current Drug Discovery Technologies, 5 (3). pp. 263-268. ISSN 1570-1638

Ory, B., Moriceau, G.D., Trichet, V. et al. (5 more authors) (2008) Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells. J Cell Mol Med, 12 (3). pp. 928-941. ISSN 1582-1838

This list was generated on Sun Mar 24 16:17:42 2024 GMT.